SERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME

Serin, Sibel; OKUTURLAR, YILDIZ; GEDİKBAŞI, Asuman; Demir, Esra; Utku, Irem; Kocoglu, Hakan; Ucak, Sema; Harmankaya, Ozlem

SERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME

Serin S. O., OKUTURLAR Y., GEDİKBAŞI A., Demir E., Utku I., Kocoglu H., ...Daha Fazla

ACTA MEDICA MEDITERRANEA, cilt.31, sa.6, ss.1271-1276, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 31 Sayı: 6
Basım Tarihi: 2015
Dergi Adı: ACTA MEDICA MEDITERRANEA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1271-1276
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Introduction: The present study aimed to evaluate and to compare Framingham Risk Score (FRS), a prediction tool for 10 year risk of coronary heart disease, and Matrix Metalloproteinase-9 (MMP-9) levels (an atherosclerotic proinflammatory marker) in patients with metabolic syndrome (MetS).